Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report)’s stock price rose 15.8% during trading on Monday . The stock traded as high as C$0.22 and last traded at C$0.22. Approximately 620,065 shares were traded during trading, an increase of 44% from the average daily volume of 429,643 shares. The stock had previously closed at C$0.19.
Voyageur Pharmaceuticals Price Performance
The company has a debt-to-equity ratio of 3.21, a current ratio of 0.17 and a quick ratio of 0.84. The company has a fifty day moving average price of C$0.09 and a 200 day moving average price of C$0.07. The company has a market capitalization of C$29.29 million, a P/E ratio of -21.00 and a beta of 0.32.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
See Also
- Five stocks we like better than Voyageur Pharmaceuticals
- 5 discounted opportunities for dividend growth investors
- Sizing Up a New Opportunity for NVIDIA Investors
- What is an Earnings Surprise?
- Is DeepSeek Challenging NVIDIA’s AI Dominance?
- CD Calculator: Certificate of Deposit Calculator
- The 3 Biggest M&A Stock Opportunities for 2025
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
